ADC Therapeutics Equity 2024

ADC Therapeutics Aktienanalyse

What does ADC Therapeutics do?

ADC Therapeutics SA is a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for the treatment of cancer. Founded in 2011, the company is headquartered in Lausanne, Switzerland. ADCs are customized drugs that consist of an antibody and a cytotoxic drug. The antibody is designed to specifically transport the cytotoxic drug to cancer cells and release it there to destroy the cancer cells. ADC Therapeutics uses a proprietary technology platform called Pyrrolobenzodiazepine (PBD) to manufacture ADCs that have high efficacy and improved safety. The company's business model involves developing and commercializing ADCs in various stages of research, clinical development, and market launch, in collaboration with partners from the pharmaceutical industry. ADC Therapeutics focuses on different types of cancer, including solid tumors such as breast cancer, lung cancer, prostate cancer, and colorectal cancer, as well as hematological tumors such as lymphomas and leukemias. The company has several ADC products in clinical development, including Camidanlumab tesirin (Cami) for the treatment of Hodgkin lymphomas and diffuse large B-cell lymphomas, and ADCT-601 for the treatment of solid tumors overexpressing the HORM2 receptor. ADC Therapeutics has also formed partnerships with other companies, such as Genmab, AstraZeneca, Adagene, and BioNTech, to further develop and commercialize its technology and products. The company aims to improve the quality of life for cancer patients worldwide by providing innovative drugs. ADC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing ADC Therapeutics's Equity

ADC Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ADC Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ADC Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ADC Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ADC Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ADC Therapeutics Stock

What is the equity of ADC Therapeutics this year?

ADC Therapeutics has equity of -148.25 M USD this year.

What was the equity of ADC Therapeutics compared to the previous year?

The equity of ADC Therapeutics has increased/decreased by -267.14% decreased compared to the previous year.

What impact does a high equity have on investors of ADC Therapeutics?

A high equity is advantageous for investors of ADC Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of ADC Therapeutics?

A low equity can be a risk for investors of ADC Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of ADC Therapeutics affect the company?

An increase in equity of ADC Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of ADC Therapeutics affect the company?

A reduction in equity of ADC Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of ADC Therapeutics?

Some factors that can affect the equity of ADC Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of ADC Therapeutics so important for investors?

The equity of ADC Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can ADC Therapeutics take to change the equity?

To change equity, ADC Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does ADC Therapeutics pay?

Over the past 12 months, ADC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ADC Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of ADC Therapeutics?

The current dividend yield of ADC Therapeutics is .

When does ADC Therapeutics pay dividends?

ADC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ADC Therapeutics?

ADC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of ADC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ADC Therapeutics located?

ADC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von ADC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ADC Therapeutics from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did ADC Therapeutics pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of ADC Therapeutics in the year 2023?

In the year 2023, ADC Therapeutics distributed 0 USD as dividends.

In which currency does ADC Therapeutics pay out the dividend?

The dividends of ADC Therapeutics are distributed in USD.